Citi tells investors it’s time to sell Moderna after 600%-plus stock gains

Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.

阅读完整 Veytics 简报

我们公开展示核心要点。创建免费账户后可继续阅读全文、保存、讨论，并结合市场和 OSINT 背景分析。